2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 66716184, 화합물
반응식
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]2[NH:15][C:16]1[CH:21]=[CH:20][CH:19]=[C:18]([CH2:22][CH2:23][N:24]([CH3:26])[CH3:25])[CH:17]=1.[Cl:27][C:28]1[CH:33]=[C:32](B2OC(C)(C)C(C)(C)O2)[CH:31]=[C:30]([Cl:43])[C:29]=1[OH:44]>>[Cl:27][C:28]1[CH:33]=[C:32]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]3[NH:15][C:16]2[CH:21]=[CH:20][CH:19]=[C:18]([CH2:22][CH2:23][N:24]([CH3:26])[CH3:25])[CH:17]=2)[CH:31]=[C:30]([Cl:43])[C:29]=1[OH:44]참가 물질
3
실험 절차
Following general procedure F, 1-{6-bromo-4-[3-(2-(dimethylamino)ethyl)phenylamino]quinolin-3-yl}ethanone (50 mg, 0.120 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (52 mg, 0.180 mmol) to afford the desired product (46 mg, 77%) as a yellow solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.31 (s, 1H), 8.20 (dd, J=8.8, 2.0 Hz, 1H), 8.00 (d, J=8.8 Hz, 1H), 7.72 (s, 1H), 7.70-7.56 (m, 2H), 7.51 (s, 1H), 7.40 (d, J=7.8 Hz, 1H), 7.10 (s, 2H), 3.40-3.30 (m, 2H), 3.21-3.11 (m, 2H), 2.94 (s, 6H), 2.82 (s, 3H); ESI MS m/z 494 [C27H25Cl2N3O2+H]+; HPLC 96.8% (AUC), tR=8.94 min.
출처 및 근거
- ORD 기록